Crewe Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $437 | Buy |
+5
| New | +$437 | ﹤0.01% | 654 |
|
|
2024
Q4 | – | Sell |
-203
| Closed | -$13.6K | – | 687 |
|
|
2024
Q3 | $13.6K | Hold |
203
| – | – | ﹤0.01% | 447 |
|
|
2024
Q2 | $23K | Sell |
203
-7
| -3% | -$794 | ﹤0.01% | 528 |
|
|
2024
Q1 | $29.1K | Buy |
+210
| New | +$29.1K | ﹤0.01% | 439 |
|
|
2023
Q3 | – | Sell |
-37
| Closed | -$4.76K | – | 680 |
|
|
2023
Q2 | $4.76K | Sell |
37
-182
| -83% | -$23.4K | ﹤0.01% | 471 |
|
|
2023
Q1 | $25.4K | Sell |
219
-62
| -22% | -$7.2K | ﹤0.01% | 384 |
|
|
2022
Q4 | $31.8K | Sell |
281
-95
| -25% | -$10.8K | 0.01% | 353 |
|
|
2022
Q3 | $30K | Buy |
376
+28
| +8% | +$2.23K | 0.01% | 389 |
|
|
2022
Q2 | $26K | Buy |
+348
| New | +$26K | 0.01% | 375 |
|
|
2021
Q4 | – | Sell |
-16
| Closed | -$2K | – | 417 |
|
|
2021
Q3 | $2K | Hold |
16
| – | – | ﹤0.01% | 352 |
|
|
2021
Q2 | $2K | Hold |
16
| – | – | ﹤0.01% | 398 |
|
|
2021
Q1 | $1K | Hold |
16
| – | – | ﹤0.01% | 434 |
|
|
2020
Q4 | $1K | Sell |
16
-12
| -43% | -$750 | ﹤0.01% | 423 |
|
|
2020
Q3 | $3K | Buy |
+28
| New | +$3K | ﹤0.01% | 437 |
|